Wellington Management Group LLP Blueprint Medicines Corp Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 4,281,364 shares of BPMC stock, worth $385 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,281,364

Previous 3,964,610 7.99%

Holding current value

$385 Million

Previous $367 Million 1.87%

% of portfolio

0.07%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$82.48 - $101.39 $26.1 Million - $32.1 Million	316,754 Added 7.99%	4,281,364 $373 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $61.3 Million - $87.9 Million	729,055 Added 22.53%	3,964,610 $367 Million
Q2 2024 Aug 13, 2024	SELL	$85.18 - $108.78 $80 Million - $102 Million	-939,597 Reduced 22.5%	3,235,555 $349 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $305 Million - $417 Million	4,175,152 New	4,175,152 $396 Million
Q4 2023 Feb 12, 2024	BUY	$43.96 - $92.84 $188 Million - $397 Million	4,276,333 New	4,276,333 $394 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $7.35 Million - $10.3 Million	156,807 Added 3.18%	5,080,521 $255 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $9.03 Million - $14.2 Million	-213,989 Reduced 4.17%	4,923,714 $311 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $5.1 Million - $6.71 Million	134,275 Added 2.68%	5,137,703 $231 Million
Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $48.4 Million - $78.4 Million	1,179,449 Added 30.84%	5,003,428 $219 Million
Q3 2022 Nov 14, 2022	BUY	$49.93 - $77.7 $66.1 Million - $103 Million	1,324,305 Added 52.98%	3,823,979 $252 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $63.7 Million - $98.9 Million	-1,409,270 Reduced 36.05%	2,499,674 $126 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $23.4 Million - $47.5 Million	431,619 Added 12.41%	3,908,944 $250 Million
Q4 2021 Feb 11, 2022	BUY	$94.25 - $115.99 $26.2 Million - $32.3 Million	278,284 Added 8.7%	3,477,325 $372 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $95.8 Million - $130 Million	1,182,979 Added 58.68%	3,199,041 $329 Million
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $56.4 Million - $68.8 Million	680,785 Added 50.98%	2,016,062 $177 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $27.1 Million - $32.3 Million	298,647 Added 28.81%	1,335,277 $130 Million
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $5.98 Million - $8.09 Million	64,963 Added 6.69%	1,036,630 $116 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $25 Million - $34.9 Million	-376,236 Reduced 27.91%	971,667 $90.1 Million
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $8.71 Million - $12.1 Million	-152,559 Reduced 10.17%	1,347,903 $105 Million
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $46.5 Million - $79.5 Million	-966,865 Reduced 39.19%	1,500,462 $87.7 Million
Q4 2019 Feb 11, 2020	BUY	$66.73 - $82.59 $165 Million - $204 Million	2,467,327 New	2,467,327 $198 Million

Others Institutions Holding BPMC

# of Institutions

380

Shares Held

65.9M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.37B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Blueprint Medicines Corp Transaction History